Your browser doesn't support javascript.
loading
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.
Teijeira, Álvaro; Garasa, Saray; Gato, María; Alfaro, Carlos; Migueliz, Itziar; Cirella, Assunta; de Andrea, Carlos; Ochoa, Maria Carmen; Otano, Itziar; Etxeberria, Iñaki; Andueza, Maria Pilar; Nieto, Celia P; Resano, Leyre; Azpilikueta, Arantza; Allegretti, Marcello; de Pizzol, Maria; Ponz-Sarvisé, Mariano; Rouzaut, Ana; Sanmamed, Miguel F; Schalper, Kurt; Carleton, Michael; Mellado, Mario; Rodriguez-Ruiz, María E; Berraondo, Pedro; Perez-Gracia, Jose L; Melero, Ignacio.
Afiliação
  • Teijeira Á; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain. Electronic address: ateijeiras@unav.es.
  • Garasa S; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain.
  • Gato M; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Alfaro C; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Migueliz I; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain.
  • Cirella A; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain.
  • de Andrea C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain; Department of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Ochoa MC; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Otano I; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Etxeberria I; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Andueza MP; Department of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Nieto CP; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain.
  • Resano L; Department of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Azpilikueta A; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Allegretti M; Dompé Farmaceutici S.p.A., 20122 Milano, Italy.
  • de Pizzol M; Dompé Farmaceutici S.p.A., 20122 Milano, Italy.
  • Ponz-Sarvisé M; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain; Department of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Rouzaut A; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Sanmamed MF; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Schalper K; Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Carleton M; Bristol Myers Squibb, Lawrence Township, NJ 08648, USA.
  • Mellado M; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), 28049 Madrid, Spain.
  • Rodriguez-Ruiz ME; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Berraondo P; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
  • Perez-Gracia JL; Department of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
  • Melero I; Program for Immunology and Immunotherapy Department, CIMA, Universidad de Navarra, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain. Electronic address: imelero@unav.es.
Immunity ; 52(5): 856-871.e8, 2020 05 19.
Article em En | MEDLINE | ID: mdl-32289253
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Quimiocinas / Receptores de Interleucina-8A / Receptores de Interleucina-8B / Armadilhas Extracelulares / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Revista: Immunity Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Quimiocinas / Receptores de Interleucina-8A / Receptores de Interleucina-8B / Armadilhas Extracelulares / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Revista: Immunity Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article